A detailed history of Lpl Financial LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 38,515 shares of AVIR stock, worth $125,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,515
Previous 35,915 7.24%
Holding current value
$125,944
Previous $118,000 9.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.17 - $4.02 $8,242 - $10,451
2,600 Added 7.24%
38,515 $129,000
Q2 2024

Aug 07, 2024

BUY
$3.31 - $4.04 $6,338 - $7,736
1,915 Added 5.63%
35,915 $118,000
Q1 2024

May 10, 2024

BUY
$3.09 - $4.56 $105,060 - $155,040
34,000 New
34,000 $137,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $272M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.